Cefazolin
NDC Package 0409-0806-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Cefazolin is a . Marketed by Hospira, Inc., this product is identified by NDC 0409-0806 and is authorized under FDA application ANDA065247.

Identification & Billing

NDC Package Code
0409-0806-01
Package Description
10 VIAL, PHARMACY BULK PACKAGE in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PHARMACY BULK PACKAGE (0409-0806-11)
Product Code
0409-0806
11-Digit Billing Format
00409080601
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
10 EA

Clinical Specifications

Proprietary Name
Cefazolin
Dosage Form
-

Regulatory & Marketing

Labeler Name
Hospira, Inc.
FDA Application #
ANDA065247
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-27-2009
End Marketing Date
10-31-2019
Listing Expiration
10-31-2019
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0409-0806-01 identifies a specific commercial package of 10 vial, pharmacy bulk package in 1 carton / 1 injection, powder, for solution in 1 vial, pharmacy bulk package (0409-0806-11) of Cefazolin, labeled by Hospira, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Hospira, Inc. on March 27, 2009. The current certification is valid through October 31, 2019.

How is this Hospira, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00409080601. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 10 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0409-0806-01
11-Digit CMS (5-4-2)
00409-0806-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.